These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3918827)

  • 1. Amyloid 'degrading factor activity': a non-specific calcium-mediated effect.
    Scott DL; Bracken P; Bacon PA; Husby G
    Clin Sci (Lond); 1985 Mar; 68(3):333-9. PubMed ID: 3918827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Amyloid degrading activity' of human serum, an in vitro clearing effect which does not involve degradation of amyloid fibrils.
    Caspi D; Baltz ML; Feinstein A; Munn EA; Pepys MB
    Clin Exp Immunol; 1984 Sep; 57(3):647-56. PubMed ID: 6467683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of the amyloid A fibril-degrading activity of human serum.
    Teppo AM; Maury CP; Wegelius O
    Scand J Immunol; 1982 Oct; 16(4):309-14. PubMed ID: 6183739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of amyloid proteins by different serine proteases.
    Skogen B; Natvig JB
    Scand J Immunol; 1981 Oct; 14(4):389-96. PubMed ID: 6461061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced amyloid-A-degrading activity in serum in amyloidosis associated with rheumatoid arthritis.
    Wegelius O; Teppo AM; Maury CP
    Br Med J (Clin Res Ed); 1982 Feb; 284(6316):617-9. PubMed ID: 6802258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum esterase activity in reactive systemic amyloidosis and its relation to amyloid A degrading activity.
    Maury CP; Junge W; Teppo AM
    J Lab Clin Med; 1984 Nov; 104(5):761-6. PubMed ID: 6092501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of reduced amyloid-A-degrading activity in serum of patients with secondary amyloidosis.
    Maury CP; Teppo AM
    Lancet; 1982 Jul; 2(8292):234-7. PubMed ID: 6124670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin D activity protects against development of type AA amyloid fibrils.
    van der Hilst JC; Kluve-Beckerman B; van der Meer JW; Simon A
    Eur J Clin Invest; 2009 May; 39(5):412-6. PubMed ID: 19740371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation of amyloid by a serum component and inhibition of degradation.
    Kedar I; Sohar E; Ravid M
    J Lab Clin Med; 1982 May; 99(5):693-700. PubMed ID: 6802914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of serum amyloid A and apolipoproteins by serum proteases.
    Bausserman LL; Herbert PN
    Biochemistry; 1984 May; 23(10):2241-5. PubMed ID: 6428449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acute phase response and its relation to amyloid A degrading activity in serum of patients with rheumatoid arthritis undergoing arthroplasty.
    Maury CP; Teppo AM; Raunio P
    Eur J Clin Invest; 1983 Feb; 13(1):73-8. PubMed ID: 6191991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid A fibril degrading activity in serum in liver disease--relation to serum acute phase and other protein levels.
    Maury CP; Teppo AM; Salaspuro MP
    Clin Chim Acta; 1983 Jun; 131(1-2):29-37. PubMed ID: 6883707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do serine proteases degrade amyloid A fibrils?
    Teppo AM; Maury CP
    Scand J Immunol; 1983 Oct; 18(4):363-6. PubMed ID: 6196837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic effects of normal sera on lymphoid cells. II. Requirements for inhibition of nonspecific serum cytotoxicity by agarose.
    Budzko DB; Kierszenbaum F
    Transplantation; 1977 Apr; 23(4):337-42. PubMed ID: 405760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abatacept may be effective and safe in patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
    Nakamura T; Kumon Y; Hirata S; Takaoka H
    Clin Exp Rheumatol; 2014; 32(4):501-8. PubMed ID: 24959698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission of systemic AA amyloidosis in animals.
    Murakami T; Ishiguro N; Higuchi K
    Vet Pathol; 2014 Mar; 51(2):363-71. PubMed ID: 24280941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signs of cross-seeding: aortic medin amyloid as a trigger for protein AA deposition.
    Larsson A; Malmström S; Westermark P
    Amyloid; 2011 Dec; 18(4):229-34. PubMed ID: 22070546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AA amyloidosis: pathogenesis and targeted therapy.
    Westermark GT; Fändrich M; Westermark P
    Annu Rev Pathol; 2015; 10():321-44. PubMed ID: 25387054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.
    Westermark GT; Westermark P
    FEBS Lett; 2009 Aug; 583(16):2685-90. PubMed ID: 19393650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy.
    Costa PP; Figueira AS; Bravo FR
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4499-503. PubMed ID: 279930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.